Metallic nanoparticles and treatment of cutaneous leishmaniasis: A systematic review.
J Trace Elem Med Biol
; 83: 127404, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38364464
ABSTRACT
BACKGROUND:
Cutaneous leishmaniasis (LC) is an infectious vector-borne disease caused by parasites belonging to the genus Leishmania. Metallic nanoparticles (MNPs) have been investigated as alternatives for the treatment of LC owing to their small size and high surface area. Here, we aimed to evaluate the effect of MNPs in the treatment of LC through experimental, in vitro and in vivo investigations.METHODS:
The databases used were MEDLINE/ PubMed, Scopus, Web of Science, Embase, and Science Direct. Manual searches of the reference lists of the included studies and grey literature were also performed. English language and experimental in vitro and in vivo studies using different Leishmania species, both related to MNP treatment, were included. This study was registered in PROSPERO (CRD42021248245).RESULTS:
A total of 93 articles were included. Silver nanoparticles are the most studied MNPs, and L. tropica is the most studied species. Among the mechanisms of action of MNPs in vitro, we highlight the production of reactive oxygen species, direct contact of MNPs with the biomolecules of the parasite, and release of metal ions.CONCLUSION:
MNPs may be considered a promising alternative for the treatment of LC, but further studies are needed to define their efficacy and safety.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leishmaniasis, Cutaneous
/
Metal Nanoparticles
Limits:
Animals
/
Humans
Language:
En
Journal:
J Trace Elem Med Biol
Journal subject:
METABOLISMO
/
SAUDE AMBIENTAL
Year:
2024
Document type:
Article
Affiliation country:
Brasil
Publication country:
ALEMANHA
/
ALEMANIA
/
DE
/
DEUSTCHLAND
/
GERMANY